Related references
Note: Only part of the references are listed.Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
Suzanne A. Eccles et al.
BREAST CANCER RESEARCH (2013)
Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer
Seigo Nakamura et al.
BREAST CANCER (2010)
Late Release of Circulating Endothelial Cells and Endothelial Progenitor Cells after Chemotherapy Predicts Response and Survival in Cancer Patients
J. M. Roodhart et al.
NEOPLASIA (2010)
Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes
L. L. Swystun et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer
C. C. Kirwan et al.
BRITISH JOURNAL OF CANCER (2008)
Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity
D. Lechner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Circulating E-selectin as a risk marker in patients with end-stage renal disease
L. S. Malatino et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes
AY Chong et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer
P. K. Y. Goon et al.
NEOPLASIA (2006)
Mechanisms of cancer-induced thrombosis
Frederick R. Rickles
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2006)
Acute pulmonary embolism in elderly: clinical characteristics and outcome
H Punukollu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine
G Numico et al.
CANCER (2005)
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes
KW Lee et al.
BLOOD (2005)
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: The Chronic Renal Impairment in Birmingham (CRIB) study
MJ Landray et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
The prothrombotic state in cancer: pathogenic mechanisms
M De Cicco
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey
CC Kirwan et al.
BRITISH MEDICAL JOURNAL (2003)
Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly
JY Wang et al.
ANTI-CANCER DRUGS (2003)
Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis
D Myers et al.
JOURNAL OF SURGICAL RESEARCH (2002)
Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma
DM O'Hanlon et al.
EUROPEAN JOURNAL OF CANCER (2002)
Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide
G Eissner et al.
BLOOD (2002)
Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase - Effect of antiapoptotic antioxidants and calcium
SV Kalivendi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Long-term chemotherapy-related cardiovascular morbidity
MT Meinardi et al.
CANCER TREATMENT REVIEWS (2000)
Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status
K Blackwell et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Activation of monocytes and endothelial cells depends on the severity of surgical stress
S Aosasa et al.
WORLD JOURNAL OF SURGERY (2000)